Delivery Order SPE2DR25D2205-SPE2DR26F1M05
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,244.00 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $35,938.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.80 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and the place of performance is also located in...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,928.27 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency has awarded a delivery order valued at $1,822.14 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count package). This firm fixed-price, non-competitive delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) under a firm fixed-price contract valued at $1,294.26. The order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and supply this pharmaceutical product to support federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,835.24 to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal inserts (18 count) on October 17, 2025, with completion scheduled for October 20, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.59 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office based in Conshohocken, Pennsylvania. The delivery location is also Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1M05Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,285.80 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count) on December 3, 2025, with an ultimate completion date of December 4, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child contract action, this delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, specifically the SPE2DX pharmaceutical prime vendor vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This modest delivery order for a gynecological medication exemplifies the company's role in supporting diverse healthcare needs within the Defense Health Agency and other federal health systems through the broader pharmaceutical prime vendor framework, which is designed to ensure reliable access to medications and supplies for military personnel and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/2/25 |